Robert C. Roberts
#159,980
Most Influential Person Now
Robert C. Roberts's AcademicInfluence.com Rankings
Robert C. Robertsphilosophy Degrees
Philosophy
#9200
World Rank
#12722
Historical Rank
Logic
#6189
World Rank
#7678
Historical Rank
Robert C. Robertsbiology Degrees
Biology
#12587
World Rank
#16073
Historical Rank
Genetics
#1384
World Rank
#1486
Historical Rank
Biochemistry
#2161
World Rank
#2306
Historical Rank
Download Badge
Philosophy Biology
Robert C. Roberts's Degrees
- PhD Biochemistry University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Robert C. Roberts Influential?
(Suggest an Edit or Addition)Robert C. Roberts's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids (2010) (3485)
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study (2012) (2002)
- A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease (2015) (1567)
- Large-scale association analysis identifies new risk loci for coronary artery disease (2012) (1507)
- A Common Allele on Chromosome 9 Associated with Coronary Heart Disease (2007) (1497)
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease (2011) (894)
- Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins (1990) (888)
- Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. (1998) (762)
- Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy (2001) (591)
- A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium (2009) (551)
- Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies (2011) (490)
- Human Genome and Diseases:¶WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases (2001) (489)
- Desmin mutation responsible for idiopathic dilated cardiomyopathy. (1999) (457)
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction (2014) (426)
- Genetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease (2010) (417)
- Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death (1993) (411)
- Functional Analysis of the Chromosome 9p21.3 Coronary Artery Disease Risk Locus (2009) (401)
- Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy (2001) (379)
- The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals (2016) (347)
- Rare Copy Number Variation Discovery and Cross-Disorder Comparisons Identify Risk Genes for ADHD (2011) (342)
- The molecular genetic basis for hypertrophic cardiomyopathy. (2001) (321)
- Shared Genetic Susceptibility to Ischemic Stroke and Coronary Artery Disease: A Genome-Wide Analysis of Common Variants (2014) (303)
- Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease (2003) (261)
- Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic Cardiomyopathy (2004) (237)
- Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. (1998) (237)
- Molecular Genetic Basis of Hypertrophic Cardiomyopathy: (1998) (230)
- Large-Scale Gene-Centric Analysis Identifies Novel Variants for Coronary Artery Disease (2011) (228)
- Recent advances in the molecular genetics of hypertrophic cardiomyopathy. (1995) (224)
- Genetically determined height and coronary artery disease. (2015) (220)
- Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. (1995) (219)
- Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls (2010) (203)
- Localization of a gene responsible for arrhythmogenic right ventricular dysplasia to chromosome 3p23. (1998) (201)
- A transgenic rabbit model for human hypertrophic cardiomyopathy. (1999) (200)
- Disruption at the PTCHD1 Locus on Xp22.11 in Autism Spectrum Disorder and Intellectual Disability (2010) (193)
- Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy (2007) (187)
- Tissue Doppler Imaging Consistently Detects Myocardial Contraction and Relaxation Abnormalities, Irrespective of Cardiac Hypertrophy, in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy (2000) (180)
- Blood pressure loci identified with a gene-centric array. (2011) (177)
- Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. (2010) (160)
- Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. (1996) (160)
- Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy (2005) (159)
- Genes and coronary artery disease: where are we? (2012) (158)
- Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk (2012) (154)
- Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction (2014) (147)
- Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. (2001) (140)
- The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14. (2000) (135)
- Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. (1998) (134)
- A Genome-Wide Association Study for Coronary Artery Disease Identifies a Novel Susceptibility Locus in the Major Histocompatibility Complex (2012) (131)
- Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. (1998) (127)
- Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a 'new diagnostic mind-set'. (1994) (119)
- Improved Prediction of Cardiovascular Disease Based on a Panel of Single Nucleotide Polymorphisms Identified Through Genome-Wide Association Studies (2010) (113)
- Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N-Oxide, a Proatherogenic Metabolite of Choline and L-Carnitine (2014) (109)
- New concepts in hypertrophic cardiomyopathies, part II. (2001) (108)
- Sudden cardiac death in hypertrophic cardiomyopathy (1995) (107)
- Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. (1997) (104)
- Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. (1995) (99)
- Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies. (2012) (99)
- Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease (2016) (97)
- Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. (1997) (95)
- Cardiac biomarkers for detection of myocardial infarction: perspectives from past to present. (2004) (95)
- Genetics: Implications for Prevention and Management of Coronary Artery Disease. (2016) (95)
- Localization of Gene for Familial Hypertrophic Cardiomyopathy to Chromosome 14ql in a Diverse US Population (1991) (91)
- Kinesin family member 6 variant Trp719Arg does not associate with angiographically defined coronary artery disease in the Ottawa Heart Genomics Study. (2009) (91)
- Genomics and cardiac arrhythmias. (2006) (89)
- Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. (2007) (82)
- Variants of trophic factors and expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy. (2000) (81)
- Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. (2005) (81)
- Modification of a Rapid Method for the Identification of Gene-Specific Polymorphisms inCryptosporidiumparvum and Its Application to Clinical and Epidemiological Investigations (2001) (79)
- Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies (2014) (78)
- Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. (1992) (78)
- A prospective follow‐up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy—The baylor experience (1996–2002) (2005) (77)
- New concepts in hypertrophic cardiomyopathies, part I. (2001) (68)
- Molecular genetics of hypertrophic cardiomyopathy. (1996) (67)
- Genetic analysis for a shared biological basis between migraine and coronary artery disease (2015) (64)
- Clinical and Genetic Association of Serum Ceruloplasmin With Cardiovascular Risk (2012) (64)
- Genetics of coronary artery disease. (2014) (62)
- Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations. (1995) (62)
- Myocardial diseases. (2000) (62)
- Genome-Wide Association Studies of Hypertension: Have They Been Fruitful? (2010) (60)
- 9p21 and the genetic revolution for coronary artery disease. (2012) (59)
- Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies. (2008) (55)
- Intravenous nitroglycerin in acute myocardial infarction. (1983) (54)
- Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events: A Mendelian Randomization Analysis (2015) (54)
- Expression of a Mutation Causing Hypertrophic Cardiomyopathy Disrupts Sarcomere Assembly in Adult Feline Cardiac Myocytes (1995) (48)
- Mechanisms of Disease: genetic mechanisms of atrial fibrillation (2006) (48)
- Human eHAND, but not dHAND, is down-regulated in cardiomyopathies. (2001) (48)
- Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. (2001) (47)
- Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia. (2001) (46)
- Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy. (2004) (46)
- Determinants of Cardiac Electrophysiological Properties in Mice (2004) (45)
- Expression of a missense mutation in the messenger RNA for beta-myosin heavy chain in myocardial tissue in hypertrophic cardiomyopathy. (1992) (45)
- Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders. (2016) (44)
- Interferon-γ activates expression of p15 and p16 regardless of 9p21.3 coronary artery disease risk genotype. (2013) (44)
- Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. (1995) (43)
- The Genome-Wide Association Study—A New Era for Common Polygenic Disorders (2010) (42)
- A genetic basis for coronary artery disease. (2015) (41)
- Identifying genes for coronary artery disease: An idea whose time has come. (2007) (40)
- Enzymatic estimation of infarct size. Thrombolysis induced its demise: will it now rekindle its renaissance? (1990) (40)
- Human protein tyrosine phosphatase-like gene: expression profile, genomic structure, and mutation analysis in families with ARVD. (2000) (39)
- The cloning, genomic organization and tissue expression profile of the human DLG5 gene (2002) (39)
- Hypertrophic Cardiomyopathy Mutation Is Expressed in Messenger RNA of Skeletal as Well as Cardiac Muscle (1993) (38)
- Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: the need for a registry. (2000) (38)
- Genetics and arrhythmias. (2003) (38)
- Genetics of coronary artery disease: an update. (2014) (38)
- Genetics of Coronary Artery Disease in the 21st Century (2012) (37)
- SPG7 variant escapes phosphorylation-regulated processing by AFG3L2, elevates mitochondrial ROS, and is associated with multiple clinical phenotypes. (2014) (36)
- Genomics in coronary artery disease: past, present and future. (2010) (34)
- A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction. (1996) (33)
- Runs of Homozygosity: Association with Coronary Artery Disease and Gene Expression in Monocytes and Macrophages. (2015) (32)
- Isolation of a de novo mutant myocardial beta MHC protein in a pedigree with hypertrophic cardiomyopathy. (1994) (31)
- Brugada syndrome: why are there multiple answers to a simple question? (2001) (31)
- Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy. (2000) (31)
- Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes (2013) (29)
- The molecular genetics of arrhythmias and sudden death (1998) (28)
- Molecular basis of hypertrophic and dilated cardiomyopathy. (1994) (27)
- Genomics in cardiovascular disease. (2013) (26)
- Genetic variants primarily associated with type 2 diabetes are related to coronary artery disease risk. (2015) (26)
- Two Chromosome 9p21 Haplotype Blocks Distinguish Between Coronary Artery Disease and Myocardial Infarction Risk (2013) (25)
- Genetic aspects of arrhythmias. (2000) (25)
- Enzymatic diagnosis of acute myocardial infarction. (1988) (25)
- Genetics of premature myocardial infarction (2008) (24)
- Molecular genetics. Therapy or terror? (1994) (24)
- To screen or not is not the question--it is when and how to screen. (2003) (23)
- Cellular oncogenes in cardiovascular disease. (1988) (21)
- Molecular and clinical aspects of inherited cardiomyopathies. (1995) (21)
- Personalized Medicine: A Reality Within this Decade (2008) (21)
- Nonsurgical Septal Reduction for Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Baylor Experience (1996–1999) (2000) (20)
- Genetic basis and pathogenesis of Familial WPW Syndrome (2003) (20)
- The transcription factor GATA-2 does not associate with angiographic coronary artery disease in the Ottawa Heart Genomics and Cleveland Clinic GeneBank Studies (2009) (20)
- The genetics of coronary artery disease (2012) (19)
- A customized genetic approach to the number one killer: coronary artery disease (2008) (17)
- Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury. (1998) (17)
- Personalized genomic medicine: a future prerequisite for the prevention of coronary artery disease. (2006) (17)
- Recent success in the discovery of coronary artery disease genes. (2011) (16)
- Molecular cloning, expression analysis, and chromosome mapping of WDR6, a novel human WD-repeat gene. (2000) (16)
- Another chromosomal locus for mitral valve prolapse: close but no cigar. (2005) (15)
- Molecular basis of cardiology (1993) (14)
- Identification and characterization of a novel gene (C4orf5) located on human chromosome 4q with specific expression in cardiac and skeletal muscle. (2000) (14)
- Prediction and management of CAD risk based on genetic stratification. (2020) (14)
- A missense mutation in the β myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy (1994) (14)
- Genetic Risk Stratification (2021) (14)
- New theories. Causes of dilated cardiomyopathy. (1998) (14)
- Familial atrial fibrillation is a genetically heterogeneous disease (1998) (13)
- Pharmacogenetics in Cardiovascular Disease: The Challenge of Moving From Promise to Realization (2014) (13)
- Genetic heterogeneity in familial dilated cardiomyopathy. (1995) (13)
- Genetics of Cardiovascular Disease with Emphasis on Atrial Fibrillation (1999) (13)
- Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval (2018) (13)
- Medical Choice in a Mexican Village (1983) (12)
- The Role of Genetic Risk Factors in Coronary Artery Disease (2014) (12)
- Genetic Testing for Early Detection of Individuals at Risk of Coronary Heart Disease and Monitoring Response to Therapy: Challenges and Promises (2011) (12)
- Early diagnosis of myocardial infarction with MB CK isoforms. (1998) (11)
- Molecular biology and atrial fibrillation. (1999) (11)
- PCSK9 inhibition--a new thrust in the prevention of heart disease: genetics does it again. (2013) (10)
- Creating a genetic risk score for coronary artery disease (2009) (10)
- Current Opinion in Cardiology (1997) (10)
- Molecular genetics of cardiomyopathies (1993) (10)
- Familial hypertrophic cardiomyopathy: diagnostic and therapeutic implications of recent genetic studies. (1996) (10)
- Molecular cardiology and genetics in the 21st century--a primer. (2006) (10)
- Definition, classification, and staging of the adult cardiomyopathies: a proposal for revision. (2004) (10)
- Genetic basis for hypertrophic cardiomyopathy: implications for diagnosis and treatment. (2003) (9)
- Review of calcium antagonist trials in acute myocardial infarction. (1989) (9)
- Genetic Risk Stratification: Tipping Point for Global Primary Prevention of Coronary Artery Disease. (2018) (9)
- Personalized cardiovascular medicine: status in 2012. (2012) (8)
- Molecular Genetics and Its Application to Cardiac Muscle Disease (1997) (8)
- Time course of recovery of regional function following thrombolysis in acute myocardial infarction (TIMI): Preliminary observations from the TIMI trial phase II (1990) (8)
- A perspective: the new millennium dawns on a new paradigm for cardiology--molecular genetics. (2000) (8)
- Inotropic therapy for cardiac failure associated with acute myocardial infarction. (1988) (7)
- La différence. Long-term benefit of one thrombolytic over another. (1996) (7)
- Stable angina as a manifestation of ischemic heart disease: medical management. (1985) (7)
- On Koch's postulates, causality and genetics of cardiomyopathies. (2002) (7)
- Disrobing the emperor (heart) without destroying the dignity of super-normality. (2002) (6)
- Genomic view of factors leading to plaque instability (2009) (6)
- Impact for molecular biology in cardiology. (1991) (6)
- Polymorphic trinucleotide repeat in the MEF2A gene at 15q26 is not expanded in familial cardiomyopathies. (1997) (6)
- Results of knockout mouse suggest impaired phosphorylation of triplet CUG binding protein pivotal to pathogenesis of cardiac and skeletal muscles dysfunction (1998) (5)
- Genetics, its role in preventing the pandemic of coronary artery disease (2021) (5)
- Thrombolytic therapy in acute myocardial infarction (1988) (5)
- A Journey through Genetic Architecture and Predisposition of Coronary Artery Disease (2020) (5)
- Molecular Analysis of Genotype/Phenotype Correlations of Hypertrophic Cardiomyopathy (1995) (5)
- Can an energy-deficient heart grow bigger and stronger? (2003) (5)
- Abstract 15730: Serum Interferon Alpha 21 is a Biomarker of the 9p21.3 Risk Locus for Coronary Artery Disease (2011) (5)
- Diltiazem in non-Q-wave myocardial infarction. (1987) (5)
- Localization of the gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse American population (1991) (5)
- Molecular Pathophysiology of Cardiomyopathies (2001) (5)
- Medical Databases (1987) (4)
- ROLE OF OXY-RADICALS IN POSTISCHEMIC MYOCARDIAL DYSFUNCTION* (1988) (4)
- Molecular genetics: Cardiac disease and risk‐related genes–Genetic risk factors (1995) (4)
- Genetics—Current and Future Role in the Prevention and Management of Coronary Artery Disease (2016) (4)
- Personalized Medicine: An Idea Whose Time Is Approaching (2007) (4)
- A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy. (1994) (4)
- Disease Genes and Gene Regulation by microRNAs (2010) (4)
- 901–88 Rapid Genetic Screen for Common β-Myosin Heavy Chain Mutations Causing Familial Hypertrophic Cardiomyopathy (1995) (4)
- Family Coronary Heart Disease: A Call to Action (2010) (4)
- Haptoglobin, the good and the bad: is it evidence based? (2013) (3)
- Historical perspective of molecular biology and the role of the cardiologist (1992) (3)
- The role of diuretics and inotropic therapy in failure associated with myocardial infarction. (1984) (3)
- The Editor's Round Table: Current Perspectives on Triglycerides and Atherosclerosis. (2016) (3)
- Genetic Diagnostic Testing for Inherited Cardiomyopathies: Considerations for Offering Multi-Gene Tests in a Health Care Setting. (2019) (3)
- Rapid MB CK subform assay and the early diagnosis of myocardial infarction. (1997) (3)
- ‘ Clinical and Population Studies Functional Analysis of the Chromosome 9 p 21 . 3 Coronary Artery Disease Risk Locus (2009) (3)
- An overview of nucleic acids and gene regulation. (1993) (3)
- Bioinformatics analysis of gene banks provides a treasure trove for the functional genomist. (2000) (3)
- Spectral estimation of cardiovascular sounds. (1978) (3)
- Genetics in the prevention and management of coronary artery disease (2018) (3)
- A Breakthrough in Genetics and its Relevance to Prevention of Coronary Artery Disease in LMIC. (2017) (3)
- The cloning, genomic organization and tissue expression profile of the human DLG5 gene: Correction (2002) (3)
- Clinical Application of Genetic Prediction in the Management of CAD (2021) (2)
- Genetic stratification for primary prevention of coronary artery disease. (2018) (2)
- Statin therapy in acute coronary syndrome. (2007) (2)
- The Essentials of Molecular Genetics (1992) (2)
- Genetic Risk Stratification and Prevention of CAD: An Idea Whose Time Is Now. (2017) (2)
- The Editor’s Roundtable: Statin Therapy in Acute Coronary Syndrome (2007) (2)
- The long-term follow-up results of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor experience (1996–2001) (2002) (2)
- Identification of myofilament mutations: its role in the diagnosis and management of hypertrophic cardiomyopathy. (2008) (2)
- Fetal ultrasound biometry revisited (1994) (2)
- Familial Atrial Fibrillation (2000) (2)
- A Breakthrough in Genetics and Prevention of Coronary Artery Disease and its Relevance to Prevention in LMIC (2017) (2)
- Introduction: First North American nitroglycerin symposium (1983) (2)
- Molecular Biology of Contractile and Cytoskeletal Proteins (1992) (2)
- Abstract 19661: Integrin Imaging for the Detection of Diffuse Myocardial Fibrosis in Patients with Hypertrophic Cardiomyopathy: Direct Comparison Between Single-Photon Emission Computer Tomography and Cardiovascular Magnetic Resonance The SCAR Study (2012) (2)
- Genomics: is it ready for primetime? (2012) (2)
- Introduction: Overview of nitrate therapy (1984) (2)
- Erratum to: “Evolution of expression of cardiac phenotypes over a 4-year period in the β-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy” [J Mol Cell Cardiol 2004; 36: 663-73] (2004) (1)
- JPH2 Mutant Gene Causes Familial Hypertrophic Cardiomyopathy (2017) (1)
- The human genome and prospects for management of cardiovascular disease (2008) (1)
- Spironolactone reverses myocyte disarray and interestitial fibrosis in the cardiac troponin T transgenic mouse model of hypertrophic cardiomyopathy (2002) (1)
- Determinants of the variability of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy (1996) (1)
- Coronary Artery Disease Gene Dosage of the Common Variant 9 p 21 Predicts Severity of Coronary Artery Disease (1)
- Molecular Biology of Cardiac Ion Channels (1992) (1)
- Essentials of Nucleic Acids and Proteins (1992) (1)
- A Less than Provocative Approach for the Primary Prevention of CAD (2021) (1)
- Improvement in right and left ventricular diastolic function with regression of hypertensive cardiac hypertrophy (1991) (1)
- The Number One Cause for Sudden Cardiac Death in the Young Unravels (2009) (1)
- Discovery of a Gene Responsible for Sudden Cardiac Death. (2017) (1)
- Molecular genetics of cardiomyopathies. (1993) (1)
- Localization of the gene for familial idiopathic dilated cardiomyopathy to chromosome 1q32 (1996) (1)
- A Primer of Molecular Biology (1992) (1)
- Editorial: combination therapy for systemic hypertension (15 September 1995). (1996) (1)
- Metoprolol prevented myocardial infarction but increased risk of stroke and death after non-cardiac surgery (2008) (1)
- Ventricular Arrhythmias After Acute Myocardial Infarction: Consideration of Arrhythmia Frequency, Complexity and Variability in Assessing Risk of Sudden Cardiac Death (1987) (1)
- MOLECULAR GENETICS OF HYPERTROPHICATHY (1995) (1)
- 839-5 Two transgenic animal models expressing human troponin T gene mutations: One exhibiting dilated cardiomyopathy (W141) and the other exhibiting hypertrophic cardiomyopathy (Q92) (2004) (1)
- Molecular biology and its impact for the future. (1991) (1)
- Positron molecular imaging, an in vivo glimpse of the genome. (2007) (1)
- Enhanced Myocardial Repair with CardioChimeras (2013) (1)
- Genomic medicine in cardiovascular disease: introduction. (2014) (1)
- A GLIMPSE OF THE 21st CENTURY FROM PRESENT DAY MOLECULAR BIOLOGY (1997) (1)
- Abstract 1436: Gene Dosage of the Common Variant 9p21 Predicts Severity of Coronary Atheromatous Burden (2008) (1)
- Modulating cardiac growth: a new paradigm in the treatment of heart failure. Introduction. (1995) (1)
- Cholesterol Surprisingly Also Induces Ventricular Hypertrophy. (2020) (1)
- Multiauthored International Publications: Something Lost in Translation? (2017) (1)
- Determining Reperfusion and Myocardial Infarct Size Using Serum Enzymes (1985) (1)
- The Genetic Challenge of Coronary Artery Disease (2010) (0)
- Molecular Genetic Basis of Cardiovascular Disease (1996) (0)
- Review Personalized Cardiovascular Medicine: Status in 2012 (2012) (0)
- Molecular genetics of familial hypertrophic cardiomyopathy (1996) (0)
- Editorial introductions. (2016) (0)
- Abstract 17862: Protection From Acute Myocardial Infarction in Humans is Associated With a Genetic Variation Near a Novel Gene Encoding a Human Protein Binding to a Mouse Model of Vulnerable Plaque (2010) (0)
- 133 Integrin Imaging of Hypertrophic Cardiomyopathy Identifies Diffuse Cardiac Fibrosis: Direct Comparison With Cardiovascular Magnetic Resonance Imaging The Scar Study (2012) (0)
- Mapping of the chromosome containing the locus for hypertrophic cardiomyopathy using polymerase chain reaction and radiation hybrids (1991) (0)
- Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a new standard of care (2002) (0)
- Abstract 18993: Genetic Variants Primarily Associated With Inflammatory Bowel Disease Do Not Associate With Coronary Artery Disease (2014) (0)
- Abstract 14363: Genetics of Coronary Atherosclerotic Plaque Rupture and Myocardial Infarction (2010) (0)
- Molecular biology of heart disease. (2011) (0)
- A genomic revolution for cardiovascular disease-a progress report at five years. (2011) (0)
- Techniques of Molecular Biology (1992) (0)
- 337 Gain-of-function variant in the mitochondrial protein SPG7 associated with increased risk of coronary artery disease (2011) (0)
- Echocardiography: a requisite friend of the cardiac geneticist. (2011) (0)
- Another Chromosomal Locus for Mitral Valve Prolapse (2005) (0)
- 278 Plasma PCSK9 Levels Do Not Predict Angiographic Coronary Artery Disease But Associate With The Risk Of Myocardial Infarction In Women Independent Of LDL Cholesterol (2012) (0)
- https://researchopenworld.com/comprehensive-risk-genetic-and-acquired-stratification-for-primary-prevention-of-cad-genetic-risk-of-cad/# (2020) (0)
- Molecular genetics of cardiomyopathies. (2000) (0)
- The Molecular Cardiology Laboratory at Baylor College of Medicine (2003) (0)
- Chapter 23. Molecular Genetics of Cardiovascular Disorders (2007) (0)
- PSeudoautosomal region 1 and predisposition to coronary artery disease. (2017) (0)
- Prolonged Exposure to S-Adenosylhomocysteine (SAH) Perturbs Adipocyte Biology (2011) (0)
- New genetic risk factors for coronary artery disease (1996) (0)
- Abstract 364: Ottawa Heart Genomic Study: Discovery Of Novel Genes For Coronary Artery Disease By Genome-wide Association Utilizing The 500k SNP Array (2007) (0)
- 272 Mechanisms of Translational Derepression During Ischemia (2012) (0)
- Abstract 914: Myozenin 2 (MYOZ2) Is a Novel Gene For Human Hypertrophic Cardiomyopathy (2006) (0)
- Molecular biology of the cardiovascular system : proceedings of a Cetus-Upjohn UCLA Symposium held at Keystone, Colorado, April 10-17, 1989 (1990) (0)
- Molecular biology for the cardiologist. (1992) (0)
- SerumCPKisoenzymes after cardiac catheterization (1975) (0)
- Genome-wide association studies --do not judge a book by its cover. (2010) (0)
- 14q1 in a diverse US population Localization of gene for familial hypertrophic cardiomyopathy to chromosome (2011) (0)
- 338 Interferon alpha 21 levels are elevated in peripheral blood lymphocytes and aortic smooth muscle cells with the 9p21.3 coronary artery disease risk genotype (2011) (0)
- FHCM as a Paradigm for Elucidating the Left Ventricular Hypertrophic Growth Response to Physiological and Pathological Stimuli (2000) (0)
- Molecular Genetics of Cardiovascular Disorders (2010) (0)
- Metoprolol prevented myocardial infarction but increased risk for stroke and death after noncardiac surgery (2008) (0)
- Temporal evolution of molecular, functional, and structural phenotypes in a transgenic rabbit model of human hypertrophic cardiomyopathy (2002) (0)
- Genetic risk stratification enables primary prevention of CAD (2020) (0)
- The Editor's Roundtable: Health reform and its implications for cardiovascular medicine. (2010) (0)
- The techniques of molecular biology and their application to the cardiomyopathies. (1994) (0)
- Abstract 16492: A Study of 63,253 Cases and 126,820 Controls Identifies Multiple Novel Loci for Coronary Artery Disease and Detects Independent Signals in Many of the Established Ones (2011) (0)
- Evidence for a shared genetic determination of Ischemic Stroke And Coronary Artery Disease - a genome-wide analysis (2013) (0)
- Abstract 2070: Identification of SPG7 as a Novel Risk Locus for Coronary Artery Disease by Genome-wide Association (2009) (0)
- The Fundamental Discoveries and Unique Features of Recombinant DNA Techniques (1992) (0)
- How Common Is a Genetic Origin of Atrial Fibrillation (2000) (0)
- Supplementary Material (nature09270-s1) (2012) (0)
- ASSOCIATION OF CYP2C19*2 TO ALTERED CLOPIDOGREL REACTIVITY AS MEASURED BY A POINT-OF-CARE ANALYSIS (2010) (0)
- 3 Genomics and Its Application to Cardiovascular Disease (0)
- Specific RNA inhibition of causal alleles: a potential therapy for familial hypertrophic cardiomyopathy. (2014) (0)
- Transport and support of cardiac patients (1990) (0)
- Medical options in chronic stable angina (1985) (0)
- Abstract 17262: Identification of a Rare Variant Near Neurexin 1 Associated with Coronary Artery Disease (2010) (0)
- Genetic risk and its role in primary prevention of CAD (2022) (0)
- 1030-10 The Severity of Left Ventricular Hypertrophy is Greater in Patients with Hypertrophic Cardiomyopathy Due to Malignant Mutations (1995) (0)
- In Memoriam: Burton E. Sobel A Tribute from Family, Friends and Colleagues October 21, 1937 – May 3, 2013 (2013) (0)
- Genetics of Atherosclerosis (2009) (0)
- Will stem cells face the same premature demise as gene therapy? (2004) (0)
- Current status of thrombolytic therapy in acute myocardial infarction. (1991) (0)
- The genetic landscape from single gene to polygenic disorders. (2010) (0)
- Genomics and Its Application to Cardiovascular Disease (2005) (0)
- The Misunderstood Gene (review) (2004) (0)
- Abstract 3451: Risk for Coronary Artery Disease at the 9p21.3 Locus Is Abolished by a Protective Locus at 8p21.3 Identified by a Genome-Wide Association Study (2008) (0)
- Preventing recurrent myocardial infarction. Use of calcium-channel blockers. (1988) (0)
- Gene therapy for cardiovascular diseases (2000) (0)
- Noninvasive detection of recanalization (1992) (0)
- NEXT GENERATION SEQUENCING FOR INHERITED CARDIOMYOPATHIES: IMPLICATIONS FOR CLINICAL PRACTICES (2017) (0)
- HYPERTROPHIC CARDIOMYOPATHY Role of Myocardial Contrast Echocardiography During Nonsurgical Septal Reduction Therapy for Hypertrophic Obstructive Cardiomyopathy (2016) (0)
- Molecular genetics of hypertrophic cardiomyopathy. (1996) (0)
- Genetic Risk Stratification and the Primary Prevention of Coronary Artery Disease (2022) (0)
- 1986 American Heart Association Bugher Program Pivotal to Current Management and Research of Heart Disease. (2018) (0)
- Mutations in human cardiac myosin binding protein C cause late-onset familiar hypertrophic cardiomyopathy (1997) (0)
- MAPPING OF A FAMILIAL DILATED CARDIOMYOPATHY GENE AND EVIDENCE FOR GENETIC HETEROGENEITY. • 204 (1996) (0)
- The Management of Q-Wave Versus Non-Q-Wave Infarction (1987) (0)
- Genetics Keeps on Giving: A Possible Vaccine for Heart Disease. (2023) (0)
- Advances in the diagnosis and treatment of coronary artery disease. Edited by Edward M. Farrell, Wilbert Joseph Keon, and Donald D. Beanlands. Blackwell Scientific Publications, Boston (1990) 355 pages, illustrated, $69.96 ISBN: 0‐86542‐055‐6 (1991) (0)
- Primary prevention of coronary artery disease based on genetic prediction (2020) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert C. Roberts?
Robert C. Roberts is affiliated with the following schools:
